By
RUDN University
Published: March 18, 2021, 1:50 p.m.·
Tags:
Vaccines
A clinical pharmacologist from RUDN University together with his colleagues from Gamaleya Research Institute of Epidemiology and Microbiology completed the second stage of a clinical trial of a new TB vaccine that was conducted with the participation of 180 volunteers. The trial confirmed the safety and efficiency of the vaccine. The results of the study were published in the Vaccines journal.
Read More →